Oxymetholone (Anadrol) increase weight and strength

Product Name: Oxymetholone (Anadrol)
Synonyms: 17-alpha-Methyl-2-hydroxymethylene-17-hydroxy-5-alpha-androstan-3-one;17-beta-androstan-3-one,17-hydroxy-2-(hydroxymethylene)-17-methyl-5-alph;17-beta-Hydroxy-2-(hydroxymethylene)-17-alpha-methyl-5-alpha-androstan-3-one;17-beta-hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-androstan-3-on;17beta-hydroxy-2-(hydroxymethylene)-17-methyl-5alpha-androstan-3-on;17-beta-Hydroxy-2-hydroxymethylene-17-alpha-methyl-3-androstanone;17-hydroxy-2-(hydroxymethylene)-17-methyl-,(alpha,17beta)-androstan-3-on;17-Hydroxy-2-(hydroxymethylene)-17-methyl-5-alpha-17-beta-androst-3-one
CAS: 434-07-1
MF: C21H32O3
MW: 332.48
EINECS: 207-098-6
Chemical Properties: Off-White to Pale Yellow Solid
MP: 172-180®C
Refractive Index: 38 ® (C=1, CHCl3)
Solubility: H2O: ≤0.5 mg/mL
Water Solubility: <0.1 g/100 mL at 23 ºC
Air & Water Reactions: Insoluble in water.
Reactivity Profile: Oxymetholone may be sensitive to light.
SYMPTOMS: Symptoms of exposure to Oxymetholone may include cholestatic jaundice, hepatocellular neoplasms and peliosis hepatitis. Prepubertal exposure may cause phallic enlargement and increased frequency of erection. Postpubertal exposure may cause inhibition of testicular function, testicular atrophy, oligospermia, impotence, chronic priapism, epididymitis, bladder irritability, clitoral enlargement, menstrual irregularities, increased or decreased libido, excitation, insomnia, nausea, vomiting, diarrhea, leukemia, gynecomastia, deepening of the voice in women, hirsutism and male-pattern baldness in women, acne, edema, retention of serum electrolytes and decreased glucose tolerance. It may also cause higher risk of developing liver cell tumors. Other symptoms include abnormal liver function tests, salt and water retention and masculinization, particularly of the female fetus.